Entrada Therapeutics, Inc. - TRDA

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$214.4M

QoQ value delta ($000)

-$107.3M (-33.34%)

Implied price effect (QoQ)

-41.57%

Total shares

29,090,435

QoQ shares delta

+3,590,055 (+14.08%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 128 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
BAKER BROS. ADVISORS LP	37,335	5,072,730	0.19%
5AM Venture Management, LLC	29,854	4,056,379	10.37%
BlackRock, Inc.	19,013	2,583,333	0.0%
Merck & Co., Inc.	12,804	1,739,768	2.43%
VANGUARD CAPITAL MANAGEMENT LLC	9,344	1,269,634	0.0%
MPM BioImpact LLC	9,222	1,253,053	0.56%
TCG Crossover Management, LLC	7,803	1,060,230	0.19%
WELLINGTON MANAGEMENT GROUP LLP	7,024	954,419	0.0%
MILLENNIUM MANAGEMENT LLC	5,622	763,959	0.0%
StepStone Group LP	5,602	761,277	0.26%
GEODE CAPITAL MANAGEMENT, LLC	5,281	717,430	0.0%
AQR CAPITAL MANAGEMENT LLC	5,148	699,537	0.0%
STATE STREET CORP	4,391	596,677	0.0%
PRICE T ROWE ASSOCIATES INC /MD/	3,992	542,316	0.0%
JPMORGAN CHASE & CO	3,827	496,457	0.0%
ACADIAN ASSET MANAGEMENT LLC	2,945	400,862	0.0%
CITADEL ADVISORS LLC	2,902	394,323	0.0%
DIMENSIONAL FUND ADVISORS LP	2,769	376,136	0.0%
NORTHERN TRUST CORP	2,281	309,942	0.0%
JACOBS LEVY EQUITY MANAGEMENT, INC	2,233	303,459	0.01%
Nantahala Capital Management, LLC	2,212	300,575	0.07%
VANGUARD PORTFOLIO MANAGEMENT LLC	1,870	254,130	0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1,450	197,136	0.0%
Longaeva Partners L.P.	1,436	195,237	0.03%
MORGAN STANLEY	1,410	191,650	0.0%